Skip to main content
SpringerLink
Log in
Book cover

EGF Receptor in Tumor Growth and Progression

  • Conference proceedings
  • © 1997

Overview

Editors:
  1. R. B. Lichtner

    1. Research Laboratories of Schering AG, Experimental Oncology, Berlin, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. R. N. Harkins

    1. Berlex Biosciences, Protein Biochemistry and Biophysics, Richmond, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Ernst Schering Foundation Symposium Proceedings (SCHERING FOUND, volume 19)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (12 papers)

  1. Front Matter

    Pages I-XIV
    Download chapter PDF

  2. Signal Transduction by EGF Receptor Tyrosine Kinase

    • R. B. Lichtner, R. N. Harkins
    Pages 1-17

  3. Characterization of Growth Factor Receptor-Directed Protein Tyrosine Phosphatases

    • F.-D. Böhmer
    Pages 19-44

  4. Interaction of Heparin-Binding EGF-Like Growth Factor with Multiple Receptors

    • K. Elenius, G. Allison, S. K. Das, B. C. Paria, S. K. Dey, M. Klagsbrun
    Pages 45-64

  5. Epidermal Growth Factor Receptor Expression in Head and Neck Tumorigenesis and Saturation of EGFR with Monoclonal Antibody RG83852

    • D. M. Shin, R. Perez-Soler, W. N. Hittelman, W. K. Hong
    Pages 65-87

  6. EGF Receptors as a Target for Therapy and Interactions with Angiogenesis

    • A. L. Harris
    Pages 89-103

  7. erbB Signalling and Endocrine Sensitivity of Human Breast Cancer

    • R. I. Nicholson, J. M. W. Gee, H. Jones, M. E. Harper, A. E. Wakeling, P. Willsher et al.
    Pages 105-128

  8. The Role of Estrogen in the Regulation of EGFR Expression

    • R. I. Yarden, M. A. Wilson, M. Barth, S. A. Chrysogelos
    Pages 129-154

  9. Multifunctional Growth Factors in Tumor Progression

    • F. Radvanyi, S. Bellusci, B. Boyer, J. Jouanneau, P. Savagner, A. M. Vallés et al.
    Pages 155-164

  10. The Role of Epidermal Growth Factor Receptor in the Initiation and Progression of Malignancy

    • K. Khazaie
    Pages 165-183

  11. Preclinical Studies with Human Tumour Xenografts Using Rat Monoclonal Antibodies Directed Against the Epidermal Growth Factor Receptor

    • S. A. Eccles, H. Modjtahedi, W. Court, J. Titley, G. Box, C. Dean
    Pages 185-209

  12. Recombinant Fusion Toxins Targeted to Members of the ErbB Family of Receptor Tyrosine Kinases

    • W. Wels, M. Schmidt, M. Jeschke, B. Groner, R. R. Beerli, N. E. Hynes et al.
    Pages 211-232

  13. EGF Receptor Inhibition by Antibody as Anticancer Therapy

    • J. Mendelsohn, J. Baselga, X. Wu, D. Peng, C. Brown, J. L. Chou et al.
    Pages 233-251

  14. Back Matter

    Pages 253-258
    Download chapter PDF
Back to top

Keywords

About this book

The last 15 years have brought an understanding of growth and differentiation at the molecular level, expanding our knowledge of the origin and progression of cancer. Early breakthroughs defining growth control pathways came via studies of oncogenes, mutated signaling molecules that have lost the capacity to tum off their proliferative signal. Oncogenes with diverse growth-promoting activities have been discovered, covering the gamut from cell surface to nuclear signaling. Sequencing of these oncogenes revealed that they were mutated forms of captured cellular genes and displayed tyrosine kinase activity. The epidermal growth factor (EGF) receptor was the first of 40-50 transmembrane tyrosine kinase receptors to be cloned and sequenced. Beyond cell proliferation, activation of EGF receptor by its specific ligands controls important physiological processes, such as cell differentiation, apoptosis, cell migration, and cell shape. Activation of autocrine growth loops, consisting in solid human tumors of upregulated expression of EGFR together with increased production of ligands suggested its crucial role in autonomous tumor growth.

Editors and Affiliations

  • Research Laboratories of Schering AG, Experimental Oncology, Berlin, Germany

    R. B. Lichtner

  • Berlex Biosciences, Protein Biochemistry and Biophysics, Richmond, USA

    R. N. Harkins

Bibliographic Information

  • Book Title: EGF Receptor in Tumor Growth and Progression

  • Editors: R. B. Lichtner, R. N. Harkins

  • Series Title: Ernst Schering Foundation Symposium Proceedings

  • DOI: https://doi.org/10.1007/978-3-662-03391-3

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1997

  • Softcover ISBN: 978-3-662-03393-7Published: 18 April 2014

  • eBook ISBN: 978-3-662-03391-3Published: 17 April 2013

  • Series ISSN: 0947-6075

  • Edition Number: 1

  • Number of Pages: XVI, 258

  • Number of Illustrations: 67 b/w illustrations

  • Topics: Oncology, Pharmacology/Toxicology, Pharmacy

Publish with us

Policies and ethics

Back to top

Search

Navigation